Trials / Unknown
UnknownNCT03129295
Phase II Proof of Concept Study in Uncomplicated UTI
A Randomized, Double-Blind, Placebo-Controlled, MultiCenter Study of the Efficacy and Safety of MPC-SHRC for the Relief of Symptoms Associated With Uncomplicated Urinary Tract Infections
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Mission Pharmacal · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study of the efficacy and safety of MPC-SHRC for the relief of symptoms associated with uncomplicated urinary tract infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MPC-SHRC | Oral tablet four times a day for 3 days |
| DRUG | Placebo Oral Tablet | Oral tablet four times a day for 3 days |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2017-04-26
- Last updated
- 2017-04-26
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03129295. Inclusion in this directory is not an endorsement.